Acute promyelocytic leukemia: where did we start, where are we now, and the future

Historically, acute promyelocytic leukemia (APL) was considered to be one of the most fatal forms of acute leukemia with poor outcomes before the introduction of the vitamin A derivative all-trans retinoic acid (ATRA). With considerable advances in therapy, including the introduction of ATRA initial...

Descripción completa

Detalles Bibliográficos
Autores principales: Coombs, C C, Tavakkoli, M, Tallman, M S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450325/
https://www.ncbi.nlm.nih.gov/pubmed/25885425
http://dx.doi.org/10.1038/bcj.2015.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450325/
https://www.ncbi.nlm.nih.gov/pubmed/25885425
http://dx.doi.org/10.1038/bcj.2015.25

Ejemplares similares